By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
MIPS reporting is seamless with the Registry.
Physical therapists providing services under Medicare Part B who meet qualifying criteria must participate in either the Merit-Based Incentive Payment Program or an Advanced Alternative Payment Model, and even PTs who aren't required to report to MIPS still may be eligible to do so voluntarily.
Boost Your Bottom Line by Opting In to MIPS
While it's true that Medicare won't update its payment formula in 2026, the coming changes could make a difference in your practice. Beginning in 2026, clinicians participating in MIPS will receive a 0.25% update, while those providing a significant portion of their services in Advanced Alternative Payment Models will receive a 0.75% update.
Between now and 2026, participating in MIPS voluntarily gives you the opportunity to earn up to an additional 9% annually. Here's how it works:
- If you are in a private practice and exceed one or two of the low-volume threshold criteria as an individual PT, you are eligible to opt in to MIPS and are subject to the payment adjustment of +/-9%.
- If your practice collectively exceeds one, two, or all three of the low-volume threshold criteria, it can opt in to MIPS as a group and is subject to the payment adjustment of +/-9%.
Measures in the Registry
The Registry supports 20 Quality Payment Program measures, three electronic clinical quality measures (CEHRT reporting only), and 11 QCDR measures — measures for every category required by MIPS.
2022 Measures
Measure 126: Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy
Measure 127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention
Measure 128: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Measure 130: Documentation of Current Medications in the Medical Record
Measure 155: Falls: Plan of Care
Measure 181: Elder Maltreatment Screening and Follow-Up Plan
Measure 182: Functional Outcome Assessment
Measure 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Measure 236: Controlling High Blood Pressure
Measure 282: Dementia: Functional Status Assessment
Measure 283: Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management
Measure 288: Dementia: Education and Support of Caregivers for Patients with Dementia
Measure 374: Closing the Referral Loop: Receipt of Specialist Report
Measure 402: Tobacco Use and Help with Quitting Among Adolescents
Measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
IROMS11: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in knee rehabilitation of patients with knee injury measured via their validated Knee Outcome Survey (KOS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID.
IROMS12: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in revalidation patients with knee injury pain.
IROMS13: Failure to Progress
Proportion of patients not achieving a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with hip, leg or ankle injuries using the validated Lower Extremity Function Scale (LEFS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID.
IROMS14: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with hip, leg or ankle (lower extremity except knee) injury.
IROMS16: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with neck pain/injury.
IROMS17: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation patients with low back pain measured via the validated Modified Low Back Pain Disability Questionnaire (MDQ) score.
IROMS18: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in revalidation patients with low back pain.
IROMS19: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with arm, shoulder, and hand injury measured via the validated Disability of Arm Shoulder and Hand (DASH) score, Quick Disability of Arm Shoulder and Hand (QDASH) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID.
IROMS20: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with arm, shoulder, or hand injury.
KEET01: Failure to Progress (FTP)
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with neck pain/injury measured via the validated Neck Disability Index (NDI).
2021 Measures
Meaure 126: Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy
Measure 127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention
Measure 128: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Measure 130: Documentation of Current Medications in the Medical Record
Measure 134: Screening for Depression and Follow-Up Plan
Measure 154: Falls: Risk Assessment
Measure 155: Falls: Plan of Care
Measure 181: Elder Maltreatment Screening and Follow-Up Plan
Measure 182: Functional Outcome Assessment
Measure 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Measure 236: Controlling High Blood Pressure
Measure 282: Dementia: Functional Status Assessment
Measure 283: Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management
Measure 286: Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia
Measure 288: Dementia: Education and Support of Caregivers for Patients with Dementia
Measure 374: Closing the Referral Loop: Receipt of Specialist Report
Measure 402: Tobacco Use and Help with Quitting Among Adolescents
Measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
IROMS11: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in knee rehabilitation of patients with knee injury measured via their validated Knee Outcome Survey (KOS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID.
IROMS12: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with knee injury pain.
IROMS13: Failure to Progress
Proportion of patients not achieving a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with hip, leg or ankle injuries using the validated Lower Extremity Function Scale (LEFS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID.
IROMS14: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with hip, leg or ankle (lower extremity except knee) injury.
IROMS15: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with neck pain/injury measured via the validated Neck Disability Index (NDI).
IROMS16: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with neck pain/injury.
IROMS17: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation patients with low back pain measured via the validated Modified Low Back Pain Disability Questionnaire (MDQ) score.
IROMS18: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with low back pain.
IROMS19: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with arm, shoulder, and hand injury measured via the validated Disability of Arm Shoulder and Hand (DASH) score, Quick Disability of Arm Shoulder and Hand (QDASH) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID.
IROMS20: Failure to Progress
Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with arm, shoulder, or hand injury.
FORCE 21: Review of Pain Status Assessment for Patients with Osteoarthritis
Percentage of patients 18 years of age and older with osteoarthritis who completed baseline and follow-up patient-reported pain status assessment and reviewed the results of this assessment with their care provider.